---
title: "Week 2 - Introduction to RNAseq"
author: "Sidharth Jain"
date: "5/26/2020"
output:
  html_document: default
  pdf_document: default
---

```{r setup, include=FALSE}
knitr::opts_chunk$set(echo = TRUE)
```


Package list:
(Use the library function to load in additional libraries)

If you're missing packages, run install.packages("packagename").
```{r}
library(tidyverse)
```

# Taking a look at CCLE RNAseq data

For this week's exercise, we're going to start digging into RNAseq expression data. The data we'll be looking at has gone through several stages of processing. Briefly, RNA is collected from each sample, usually with technical replicates, and fragmented (read more about RNAseq experiment preparation [here](https://www.neb.com/tools-and-resources/usage-guidelines/getting-started-with-rna-seq)). A sequencing machine will produce fixed-length reads from the prepared RNA library, and identify the sequences. This information is stored in a file format called `.fastq`, which captures both the actual nucleotide sequence, as well as the quality of the read from each nucleotide. Sequences are then aligned to the genome to identify which gene they originated from, and the number of alignments to each gene creates a "gene count", which represents how expressed each gene was in the cell.

The counts are then normalized by the length of the gene/region of the genome they emerged from. Currently, we used either RPKM, FPKM, or TPM to present normalized RNAseq readouts. You can read more about the similarities/differences [here](https://www.rna-seqblog.com/rpkm-fpkm-and-tpm-clearly-explained/#:~:text=Here's%20how%20you%20calculate%20TPM,divide%20this%20number%20by%201%2C000%2C000.), but just remember that we now have a standard way of comparing one gene's expression to another. Using this data, we can now compare expression of genes within a single sample. To compare between different samples, we'll also need to normalize between samples using more complicated normalization techniques.

We'll be diving into RNAseq experiments in much greater depth later on, but for now, we just need to understand how the data we're working with was acquired. Using this data, we'll be trying to accomplish a few goals:

- Clean and match the RNAseq data, mutation data, and CCLE metadata
- Isolate the expression and mutation data for a gene of interest. 
- Visualize the patterns in the expression and mutation data
- Show the relationship between expression and mutation

### Loading the data
Let's load in the data. This week, we'll be using slightly different CCLE metadata compared to last week. We'll also be using the mutation and expression data (which has been reported in TPM). 

NOTE!!!! You're only working with a slice of the mutation and expression data (since the full datasets could not be uploaded to the cloud). I'll be sending out the full datasets later in the week, so you're free to run these on your local machines with the full data (just change the read_csv functions below to point to the full files).

(NB: I set the warnings and messages in the Rmarkdown chunk below to false to hide all of the output from readr functions)
```{r, warning=FALSE, message = FALSE}
# Unlike last time where we used the read.delim() function of base R,
# we'll be using the readr package's read_csv() function.
CCLE_metadata <- read_csv("sample_info.csv")

# These next lines might take a little while to run - try not to run them too many times!
CCLE_expression <- read_csv("CCLE_expression-subset.csv")

CCLE_mutations <- read_csv("CCLE_mutations-subset.csv")
```

The expression data has cell lines in the first column (with an ACH ID), and gene expression in the other columns.

The mutation data is complicated, and we won't really worry too much about it right now, except to isolate mutations in the gene KRAS, as done below. Note that once we get the mutations of KRAS, and merge that data with the CCLE metadata, we don't really need to use the rest of the mutation data. However, you may want to come back to this dataset for any other analyses or questions you may think about!

```{r}
# Our goal here is to extract the relevant parts from the mutation data 
# to merge it with the CCLE_metadata.

kras_mutations <- CCLE_mutations %>%
  # Filter for only KRAS mutations
  filter(Hugo_Symbol=="KRAS") %>% 
  # Select for the columns we need to merge our data
  select(Hugo_Symbol, DepMap_ID, Protein_Change, Codon_Change)

# To make our lives easier, we're going to merge the CCLE_metadata 
# with the kras_mutations data. By doing this, we're annotating
# each cell line with the Protein_Change or Codon_Change in KRAS that
# it has. 
CCLE_metadata <- merge(CCLE_metadata, kras_mutations, all.x = T)
```

### Exploring the data
First, let's look at how many rows and columns are in the RNAseq data.
```{r}
# Get the number of rows and number of columns separately
nrow(CCLE_expression)
ncol(CCLE_expression)

# Alternatively, use the dim() function to get a printout of 2 numbers
# Rows, columns
dim(CCLE_expression)
```

So from this, it looks like we have 1,305 rows, and 101 rows. If you had guess, which one represents the number of cell lines, and which represents the number of genes?

As you might have guessed, there are under ~1400 cell lines, so each row represents a cell line with RNAseq data (not all cell lines have data!).And there are only 100 genes being reported here, as I had to subset the data for the cloud.. That would mean that we would have `r format(1305*101, scientific = F)` different points of data in this dataset.

Let's take a peek at the data to see what we're actually working with.
```{r, echo = T, eval = F}
CCLE_expression[1:3,1:3]
```
```{r, echo = F, eval = T}
knitr::kable(CCLE_expression[1:3,1:3])
```

## Why tidy data?

When we encounter a new dataset, we want to first try to make our data *tidy*. What is tidy data? Generally, for tidy data, we want each row to consist of an observation, a column to describe a type of variable (or key), and value that matches with that variable (or value). We can use `gather` and `spread` to make our data a more tidy format. Tidy data is useful in that it becomes easier to take pieces of data that would be more useful. We can also spread our data so that we can view all of the observations for a single sample, which might be useful to better understand how each cell line is behaving, and compare different features of each cell line. For the purposes of the analysis we do here, we want a dataframe where each row is a cell line, and each column describes some feature about that cell line -- which is a similar format to our CCLE_metadata dataframe. This format isn't EXACTLY tidy, but we can achieve this format from a tidy dataset by `spread`ing it.

### Tidying the RNAseq data

So the first thing to note is that the first column doesn't contain any RNA expression data! Instead, it contains an ID that looks like ACH-XXXXXX, which is an identifier for the cell line. It should match up with the `DepMap_ID` column in the CCLE_metadata.

The second thing to note are the other columns that each represent a gene. The format of these is SYMBOL (EntrezID). SYMBOLS are the gene names we're most familiar with, while the Entrez ID is a format that's used to maintain databases of genes, and can help identify homologs in other species, for example.

Here, I create a new `CCLE_combined` dataframe that combines the metadata and expression dataframes, using the `merge` function. Merge takes two dataframes and combines them using any columns that have the same name. This gets all of the information that we'll need to visualize and understand in a single dataframe, which we can then use to compare expression and mutation side by side.

Here, I also use the `mutate` function to add new columns to the `CCLE_expression` dataframe. Mutate simply allows us to change the columns in the dataframe, either by adding new columns, or modifying existing columns. One cool thing is that in line #118 (marked by the `***`), I'm using mutate to refer to an existing column in the dataframe to create a new column. 
```{r}

people <- data.frame(
  name = c("Paloma", "Emily", "Carlos"),
  description = c("cool", "awesome", "nice")
)

position_of_people <- data.frame(
  name = c("Carlos", "Emily", "Antonio"),
  position = c(1,2,3)
)

merged_people <- merge(people, position_of_people)


# Create a new CCLE_combined dataframe that brings together the metadata and expression data.
CCLE_combined <- CCLE_expression %>%
  # Rename the 1st column to DepMap_ID (because that's what it actually represents)
  # This will also allow the merge function to merge by the DepMap_ID.
  rename(DepMap_ID = X1) %>%
  # Use the merge function to combine all of the expression data with the metadata
  merge(CCLE_metadata) %>%
  # Add a column of TRUE or FALSE, indicating if KRAS is mutated or not
  # If codon change is NOT NA (the ! means NOT), then set the value to TRUE.
  mutate(KRAS_mutated = !is.na(Codon_Change)) # *** #
  
# CCLE_combined isn't a tidy data, but we'll make it tidy every time we use it to create a figure or perform a statistical test.
```

# Understanding RNA expression patterns

Now that we've loaded in and cleaned up our data a little, let's start looking at some of the patterns in the data. One way we can easily understand the full scope of the data is by visualizing it with a histogram. Histograms are useful because they let us see the full range of data, and help us identify any outliers or what the overall distribution of the data is.

Let's visualize what the expression of one gene across many cell lines looks like. We can narrow down the dataframe to select columns that we want to use with the `select` function.
```{r}
# First, pick a gene of interest. Here, we'll look at KRAS expression.
# Note: By doing the following, I'm creating a tidy dataset! Each row is an observation, and each column describes that observation.
KRAS_data <- CCLE_combined %>%
  # Pick the columns of interest (renaming the KRAS data to KRAS_expression)
  select(KRAS_expression = `KRAS (3845)`, CCLE_Name, KRAS_mutated)

# Now let's visualize with ggplot - note that with ggplot, we don't need to quote anything!
ggplot(data = KRAS_data, mapping = aes(x = KRAS_expression)) +
   # Let's use a histogram to visualize the distribution of expression across cell lines
  geom_histogram()

# If you noticed, we got a warning saying that we should pick a better binwidth value. 
# That's why we can't see as much of the granularity of the data as we want to.
# So let's try making another histogram, this time with more bins.
ggplot(data = KRAS_data, mapping = aes(x = KRAS_expression)) +
  geom_histogram(bins = 100)
```

So it looks like there is a wide spread of cell lines expressing KRAS. There are also some outlier cell lines that seem to be expressing very high levels of KRAS. In the Stephens et al. 2017 paper you were assigned to read, the authors explored the relationship between KRAS expression and KRAS mutation. Let's try to separate KRAS mutant cell lines from KRAS wild-type cell lines to see if there's a difference between the distributions in KRAS expression. To do this, we can add another dimension to our histogram by adding a fill color, which we'll link to the variable `KRAS_mutated`. 

```{r}
# Use KRAS_mutated as a fill, to color by KRAS mutant status
ggplot(data = KRAS_data, mapping = aes(x = KRAS_expression, fill = KRAS_mutated)) +
  geom_histogram(bins = 100)
```

Another way to visualize this data might be with a boxplot. Boxplots are useful in that they show us where the median/quartiles of the data are, and allow us to more direclty compare two groups. Here, we make a boxplot comparing the same two groups.

```{r}
ggplot(data = KRAS_data, aes(x = KRAS_mutated, y = KRAS_expression)) +
  geom_boxplot() +
  labs(x = "Mutation", y = "Expression")
```

And a way to combine the nuances of a histogram with the delineated nature of a boxplot would be a violin plot, seen here:
```{r}
ggplot(data = KRAS_data, aes(x = KRAS_mutated, y = KRAS_expression)) +
  geom_violin()
```

What conclusions can you draw from these graph about the difference in KRAS expression between KRAS mutant and KRAS wildtype cells? Does it look like there is a meaningful difference between the two groups? How might you determine if there is a statistical difference between the two groups? No need to answer, just food for thought!


### Looking at differences between tissue types
Another difference we may want to take a closer look at is how different tissue types may impact KRAS expression. Biologically, different tissues express different transcription factors, so this may in fact explain a large proportion of variability in expression.

The first thing we want to do is understand which tissue types tend to have higher or lower expression.

```{r}
# Again, let's create a new dataframe with the data we want to visualize.
KRAS_data <- CCLE_combined %>%
  # Pick the columns of interest (renaming the KRAS data to KRAS_expression)
  select(KRAS_expression = `KRAS (3845)`, lineage) 

# Make a boxplot, colored by tissue (lineage), for each tissue's expression of KRAS.
ggplot(data = KRAS_data, 
       aes(x = lineage, y = KRAS_expression, fill = lineage)) +
  geom_boxplot() +
  theme(legend.position = 'none', #Remove the legend (it's the same as the x-axis)
        # Rotate the x-axis labels by 45 degrees, and offset them.
        axis.text.x = element_text(angle = 45, vjust = 1, hjust = 1)) 
```

So we can see the ranges of KRAS expression in different lineages. In the Stephens et al. 2017 paper you were assigned to read, the authors explored the relationship between KRAS expression and KRAS mutation. In the questions below, you'll be recreating and expanding on some of their analyses, showing the relationships between KRAS mutation and KRAS expression.

# Questions
> Mutations in the KRAS gene occur in most pancreas and many lung, colorectal and uterine corpus endometrial cancers. Less frequent KRAS mutations have been observed in cancers of the breast, cervix, hepatobiliary duct and testicular germ cell.

* Q1. Load in CCLE's cell line annotations. For each type of cell line ("lineage" in annotation), what is the number of cell lines that has a KRAS mutation?  Use a barplot to display it: x-axis is the cell line type, y-axis is the count. Then, sort the barplot with the most frequent disease type to come first, least frequent disease type to come last (hint: try making lineage an ordered factor using the `factor()` function, and be sure to specify levels!).

```{r}
KRAS_data <- CCLE_combined %>%
  # Pick the columns of interest (renaming the KRAS data to KRAS_expression)
  select(KRAS_expression = `KRAS (3845)`, lineage, KRAS_mutated) 





ggplot(data = KRAS_data,      
       aes(x= reorder(factor(cancer_type), cancer_type, function(x) length(x)), fill=KRAS_mutated)) +
       theme(
       axis.text.x = element_text(angle = 45, vjust = 1, hjust = 1))+
       geom_bar()

```

> In cancer, mutations (primarily in codons 12, 13, and 61) render Ras proteins resistant to GAP-assisted GTP hydrolysis resulting in a constitutively active RAS molecule. Less frequently, mutations occur (eg, at alanine 146) that lower the affinity of Ras proteins for GDP, allowing exchange of GDP for GTP without upstream signaling through GEFs. Importantly, these activating mutations in KRAS affect both the KRAS4A and KRAS4B isoforms.

* Q2. Take a look at the columns "Codon_Change" and "Protein_Change". This gives information about which codon is mutated and the context of the mutation. Again, make a barplot documenting the count of the different types of codon/protein changes in KRAS. Where do the majority of codon/protein changes occur? Can you infer anything about that site?
Hint: The ggplot geometry for barplots is geom_bar()

```{r}
# Put your answer here:
```


> In addition to point mutations that increase RAS activity, RAS genes are often amplified in human cancers. For example, KRAS is frequently amplified in ovarian, lung squamous cell, uterine, adrenocortical, and esophageal tumors. This suggests that both mutation and expression levels contribute to the roles that RAS genes play in oncogenesis.
We first focused on KRAS and its KRAS4A and KRAS4B isoforms within the TCGA tumor types in which KRAS is frequently mutated. Figure 1A shows expression levels for KRAS in lung adenocarcinoma (LUAD), pancreatic ductal adenocarcinoma (PAAD), and colon adenocarcinoma (COAD) samples. In each tumor type, we observed statistically significant increases in expression of mutant KRAS using the t test. The values are shown on the figure along with the numbers of samples for each condition.

* Q3. Using the RNAseq expression data AND mutation data, we want to identify if there is a significant relationship between KRAS mutation and expression. Subset to lung cancer cell lines only and create a boxplot of KRAS expression dependent on KRAS WT/MUT. Does your figure resemble Fig. 1? Why or why not? Do the same for pancreatic and colorectal lines.
BONUS: Perform a t-test to see if there is a difference in KRAS expression between KRAS wild-type and KRAS mutant cell lines. Hint: The R function `t.test` can take two numeric vectors and perform a t.test between them.
```{r}
# Put your answer here:
```

* Q4. Upstream of KRAS is the receptor tyrosine kinase EGFR. EGFR is often the driver mutation in non-KRAS driven cancers, and, interestingly, EGFR mutations tend to be mutually exclusive with KRAS mutations.  In fact, this is addressed in the paper:

> In the bars at the bottom of the plot, the positions of samples with mutations in TP53, epidermal growth factor receptor (EGFR), KEAP1, and NF1 are indicated. Of these, the EGFR mutations do seem to be enriched toward the left side of the panel, indicating lowered KRAS expression. Although the TP53 mutations are enriched in the non-KRASâ€“mutated samples (data not shown), that relationship is not evident on the plot. We did not see any enrichment of either KEAP1 or NF1 in terms of KRAS expression levels. The EGFR relationship is expected as KRAS mutations and EGFR mutations are mutually exclusive.

We can follow this up by looking at EGFR mutations with EGFR expression, in the same way we explored KRAS above. Do EGFR-mutated cell lines also express EGFR higher than EGFR-wildtype cell lines? Hint: Everything I did above!

```{r}
# Put your answer here:
```

*Q5. BONUS: Are there any other genes or pathways that you're interested in? Find another piece of analysis in the paper that you find interesting, and see whether it validates in the CCLE dataset. OR -- feel free to think beyond the scope of this paper or your readings. What kinds of questions can you ask with a combination of mutation and expression data for all of these different cell lines/tissue types?


